兔宝宝(002043) - 2021 Q1 - 季度财报

Financial Performance - The company's operating revenue for Q1 2021 reached ¥1,367,232,426.29, representing a 188.01% increase compared to ¥474,724,832.65 in the same period last year[8]. - Net profit attributable to shareholders was ¥102,832,626.18, a significant turnaround from a loss of ¥28,333,211.17, marking a 460.13% increase[8]. - The net profit after deducting non-recurring gains and losses was ¥71,585,614.75, compared to a loss of ¥22,684,808.93 in the previous year, reflecting a 462.94% increase[8]. - The basic earnings per share improved to ¥0.13 from a loss of ¥0.04, indicating a 425.00% increase[8]. - The weighted average return on net assets was 5.70%, up from -1.61% in the same period last year, an increase of 7.31%[8]. - Total revenue increased by RMB 892.51 million, a year-on-year increase of 188.01% due to the recovery from COVID-19 impacts[16]. - Net profit attributable to the parent company increased by RMB 131.17 million, a year-on-year increase of 462.94%[18]. - The total operating revenue for the first quarter of 2021 reached CNY 1,367,232,426.29, a significant increase from CNY 474,724,832.65 in the same period last year, representing a growth of approximately 187.4%[49]. - The net profit for the first quarter of 2021 was CNY 103,761,999.95, compared to a net loss of CNY 35,466,180.68 in the previous year[53]. - The total comprehensive income for the first quarter of 2021 was CNY 104,529,449.44, compared to a loss of CNY 34,518,107.84 in the previous year[53]. Cash Flow - The net cash flow from operating activities was -¥284,262,002.06, an improvement of 39.94% from -¥473,304,932.46 in the previous year[8]. - Cash flow from operating activities increased by RMB 189.04 million, a year-on-year increase of 39.94%, driven by higher cash receipts from sales[18]. - Cash inflow from operating activities amounted to ¥1,682,940,899.17, a significant increase from ¥606,727,985.13 in the previous period, representing a growth of approximately 177.5%[59]. - The cash outflow for investment activities was ¥674,343,072.89, down from ¥1,433,579,787.16, reflecting a decrease of approximately 53.0%[61]. - The net cash flow from investment activities was ¥190,804,442.04, a recovery from -¥495,844,107.11 in the previous year, showing a positive turnaround[61]. - Cash inflow from financing activities was ¥650,511,946.96, an increase from ¥518,826,695.89, marking a growth of approximately 25.3%[63]. - The ending balance of cash and cash equivalents was ¥658,947,958.83, compared to ¥267,789,894.31 in the previous period, representing an increase of approximately 146.1%[63]. Shareholder Information - The company had a total of 46,203 common shareholders at the end of the reporting period[11]. - The largest shareholder, Dehua Group Holdings Co., Ltd., held 29.60% of the shares, totaling 229,344,885 shares[11]. - The company repurchased 17,450,102 shares, accounting for 2.25% of total share capital, with a total payment of RMB 169.07 million[19]. Assets and Liabilities - Total assets at the end of the reporting period were ¥4,975,177,654.07, a decrease of 5.77% from ¥5,279,564,958.61 at the end of the previous year[8]. - The total liabilities decreased to CNY 2,961,598,946.02 from CNY 3,210,945,094.83, reflecting a reduction of about 7.8%[45]. - The company's current assets totaled CNY 2,994,355,762.58 as of March 31, 2021, down from CNY 3,361,322,602.95 at the end of 2020[39]. - The company's long-term equity investments decreased to CNY 35,735,671.69 from CNY 60,660,968.19, indicating a reduction in long-term investment holdings[41]. - The total current liabilities increased to CNY 2,758,893,264.38 from CNY 2,917,169,619.42, indicating a rise of about 5.4%[45]. Operational Insights - Operating costs rose by RMB 756.88 million, a year-on-year increase of 196.22%, corresponding to the increase in revenue[16]. - The company's operating costs for the first quarter were CNY 118,532,265.71, up from CNY 65,618,410.03, reflecting increased operational activities[56]. - Research and development expenses increased by RMB 4.73 million, a year-on-year increase of 57.15%, reflecting increased investment in R&D[16]. - Research and development expenses increased to CNY 12,992,500.10, up from CNY 8,267,496.74, reflecting a focus on innovation[51]. Investment and Risk Management - The company reported a net profit of 72.5 million CNY from entrusted financial management, with an outstanding balance of 28.8 million CNY[27]. - The company has engaged in high-risk entrusted financial management, with a total amount of 72.5 million CNY allocated[27]. - The company has not reported any overdue amounts from entrusted financial management, indicating effective risk management[27]. - There were no derivative investments reported during the period, indicating a conservative investment strategy[25]. - The company is focusing on maintaining a stable financial position without engaging in high-risk investments[31]. - The company has not indicated any plans for new product launches or technological advancements in the near term[30]. - There are no reported mergers or acquisitions during the reporting period, suggesting a focus on organic growth[30].